Group v secretory phospholipase A2 plays a pathogenic role in myocardial ischaemiareperfusion injury

Cardiovascular Research

Volumn 90, Issue 2, 2011, Pages 335-343

  Yano, Toshiaki ^a   Fujioka, Daisuke ^a   Saito, Yukio ^a   Kobayashi, Tsuyoshi ^a   Nakamura, Takamitsu ^a   Obata, Jun Ei ^a   Kawabata, Kenichi ^a   Watanabe, Kazuhiro ^a   Watanabe, Yosuke ^a   Mishina, Hideto ^a   Tamaru, Shun ^a   Kugiyama, Kiyotaka ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Infarction; Ischaemia; MAP kinase; Myocytes; Phospholipases

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; CASPASE 8; LEUKOTRIENE B4; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOLIPASE A2; STRESS ACTIVATED PROTEIN KINASE; THROMBOXANE B2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOSOL; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENOTYPE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PREMEDICATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; WILD TYPE;

ANIMALS; ARACHIDONIC ACID; CASPASE 3; CASPASE 8; CELLS, CULTURED; ECHOCARDIOGRAPHY; ENZYME INHIBITORS; GROUP IV PHOSPHOLIPASES A2; GROUP V PHOSPHOLIPASES A2; IN SITU NICK-END LABELING; LEUKOTRIENE B4; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; THROMBOXANE B2;

EID: 79955380338     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq399     Document Type: Article

References (37)

1. 2 regulation of arachidonic acid mobilization. FEBS Lett 2002;531:2-6. (Pubitemid 35232775)
2. 2. Biol Pharm Bull 2004;27: 1158-1164. (Pubitemid 41701703)
3. 2. Prostaglandins Leukot Essent Fatty Acids 2003;69: 87-97. (Pubitemid 36980617)
4. 2\a mediator between proximal and distal effectors of inflammation. Immunol Today 1991;12:143-146.
5. Jenkins CM, Cedars A, Gross RW. Eicosanoid signalling pathways in the heart. Cardi-ovasc Res 2009;82:240-249.
6. Sen A, Buja LM, Willerson JT, Chien KR. Membrane phospholipid metabolism during myocardial ischaemia: past, present and future. Basic Res Cardiol 1987;82(Suppl. 1): 121-125. (Pubitemid 17114086)
7. 2 and C in myocardial ischemic reperfusion injury. Am J Physiol Heart Circ Physiol 1991;260:H873-H877.
8. 2-mediated hydrolysis of cardiac phospholipids: the use of molecular and transgenic techniques. Mol Cell Biochem 1998;180:65-73. (Pubitemid 28118805)
9. 2. J Lipid Mediat Cell Signal 1995;12:131-137.
10. Schrör K, Thiemermann C. Eicosanoids in myocardial ischemia. Biomed Biochim Acta 1989;48:729-734. (Pubitemid 20131399)
11. van Bilsen M, Engels W, van der Vusse GJ, Reneman RS. Significance of myocardial eicosanoid production. Mol Cell Biochem 1989;88:113-121. (Pubitemid 19203206)
12. 2 gene family in mammals. J Biol Chem 1997;272:17247-17250. (Pubitemid 27311145)
13. 2. Cloning, tissue distribution, and functional expression oftwo novel mouse group II enzymes. J Biol Chem 1999;274:31195-31202.
14. 2s. Biochim Biophys Acta 2000;1488:159-166.
15. 2s containing 16 cysteines. J Biol Chem 1994;269:2365-2368.
16. Sawada H, Murakami M, Enomoto A, Shimbara S, Kudo I. Regulation oftype V phos-pholipase A2 expression and function by proinflammatory stimuli. Eur J Biochem 1999; 263:826-833. (Pubitemid 29361956)
17. 2 in myocardial remodelling after infarction. Histo-pathology 2005;47:257-267. (Pubitemid 41243263)
18. 2a activation. Blood 2007;110:561-567. (Pubitemid 47105394)
19. 2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol 2007;27:600-606.
20. 2s. J Immunol 2009;182:3877-3883.
21. 2a activity that is responsible for arachidonic acid release. J Biol Chem 2003;278:24153-24163. (Pubitemid 36830251)
22. 2. J Biol Chem 2002;277:36479-36488.
23. 2s. Biochim Biophys Acta 2006;1761: 1317-1322. (Pubitemid 44738706)
24. 2. J Biol Chem 1997; 272:16709-16712.
25. 2. J Lipid Mediat Cell Signal 1995;12:83-117.
26. 2 during simulated ischaemia/reperfusion-induced injury in neonatal cardiac myocytes. Prosta-glandins Leukot Essent Fatty Acids 2007;77:37-43. (Pubitemid 47248255)
27. 2 signaling pathway in blood-brain barrier disruption after focal cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 2008;28:1686-1696.
28. 2. J Biol Chem 1994;269:13057-13061.
29. Kobayashi T, Watanabe Y, Saito Y, Fujioka D, Nakamura T, Obata JE et al. Mice lacking the glutamate-cysteine ligase modifier subunit are susceptible to myocardial ischaemia-reperfusion injury. Cardiovasc Res 2010;85:785-795.
30. 2-deficient mice. Circulation 2008;117:2977-2985.
31. 2 gene in inbred mouse strains. J Biol Chem 1995;270:22378-22385.
32. 2 promotes striated muscle growth. Nat Med 2003;9:944-951. (Pubitemid 36889939)
33. 2s. J Biol Chem 1999;274:12263-12268.
34. 2 isoforms in the checkpoint control of acute inflammation. FASEBJ 2004; 18:489-498. (Pubitemid 38326305)
35. 2 activities for the treat-ment of inflammatory conditions. Biochim Biophys Acta 2006;1761:1373-1382. (Pubitemid 44738708)
36. Hii CS, Huang ZH, Bilney A, Costabile M, Murray AW, Rathjen DA et al. Stimulation of p38 phosphorylation and activity by arachidonic acid in HeLa cells, HL60 promye-locytic leukemic cells, and human neutrophils. Evidence for cell type-specific acti-vation of mitogen-activated protein kinases. J Biol Chem 1998;273:19277-19282. (Pubitemid 28366328)
37. 2. Biochim Biophys Acta 2006;1761:1289-1300. (Pubitemid 44738703)